|
Press Releases |
|
 |
|
Tuesday, May 28, 2024 |
|
CR Pharmaceutical Armed with Leading Advantages Releases Growth Potential and Achieves High-quality Sustainable Development |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320.HK), recorded total revenue of RMB244,703.9 million last year, a 12.2% climb year-on-year, and net profit of RMB 7,775.0 million, a 16.8% increase year-on-year. more info >> |
|
Monday, November 14, 2022 |
|
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022. more info >> |
|
Monday, January 20, 2020 |
|
安捷證券第二輪藥品集採結果:降價主旋律不變,首推創新型龍頭 |
2020年01月17日,第二輪國家集採正式開標,結果如下:122家企業參與採購,33個(按通用名計)藥品的194個品規激烈厮殺,價格降幅超出市場預期。 more info >> |
|
Tuesday, July 2, 2019 |
|
华润医药再度蝉联资本杰出中国企业成就奖 |
华润医药集团有限公司(「华润医药」或「集团」;股份编号:3320)欣然宣布,集团于《资本杂志》主办的第十四届「资本杰出中国企业成就奖」中再度获选为「资本杰出中国医药集团」,彰显集团在过去一年于业务上的杰出表现及其稳固的发展潜力。 more info >> |
|
華潤醫藥再度蟬聯資本傑出中國企業成就獎 |
華潤醫藥集團有限公司(「華潤醫藥」或「集團」;股份編號:3320)欣然宣佈,集團於《資本雜誌》主辦的第十四屆「資本傑出中國企業成就獎」中再度獲選為「資本傑出中國醫藥集團」,彰顯集團在過去一年於業務上的傑出表現及其穩固的發展潛力。 more info >> |
|
Friday, August 25, 2017 |
|
华润医药中期业绩增长理想 实现收益约港币827亿元 |
华润医药集团有限公司(「华润医药」)或「集团」;股份编号:3320)公布截至2017年6月30日止年度(「期内」)的中期业绩。 more info >> |
|
華潤醫藥中期業績增長理想 實現收益約港幣827億元 |
華潤醫藥集團有限公司(「華潤醫藥」)或「集團」;股份編號:3320)公佈截至2017年6月30日止年度(「期內」)的中期業績。 more info >> |
|
China Resources Pharmaceutical Delivers Solid Interim Results; Half-year Revenue Reaches HK$82.7 Billion |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320), announced its interim results for the six months ended 30 June 2017 ("Reporting Period"). more info >> |
|
Monday, March 20, 2017 |
|
华润医药全年业绩稳健增长 实现收益约港币1,567亿元 |
华润医药集团有限公司(「华润医药」)或「集团」;股份编号:3320)公布截至2016年12月31日止年度(「年内」)的全年业绩。 more info >> |
|
華潤醫藥全年業績穩健增長 實現收益約港幣1,567億元 |
華潤醫藥集團有限公司(「華潤醫藥」)或「集團」;股份編號:3320)公佈截至2016年12月31日止年度(「年內」)的全年業績。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
第十屆【華富卓越投資者關係大獎】頒獎典禮圓滿舉行
Jul 10, 2025 15:52 HKT/SGT
|
|
|
The 10th Quam IR Awards was Successfully Held
Jul 10, 2025 15:12 HKT/SGT
|
|
|
第十届【华富卓越投资者关系大奖】颁奖典礼圆满举行
Jul 10, 2025 15:09 HKT/SGT
|
|
|
港交所單日「五連發」聯控體系貢獻近半
Jul 10, 2025 14:47 HKT/SGT
|
|
|
港交所单日“五连发” 联控体系贡献近半
Jul 10, 2025 14:45 HKT/SGT
|
|
|
Tianci international: Discussing Strategic Opportunities for the Shipping and Logistics Industry to Integrate with Blockchain technology and RWA
Jul 10, 2025 12:30 HKT/SGT
|
|
|
Tradable Bits Powers Fan Engagement for Rugby Australia's Hosting of the Qatar Airways British & Irish Lions Men's Tour 2025
Jul 10, 2025 07:30 HKT/SGT
|
|
|
Hola Prime Unveils 'Hola Prime Futures' with Industry-First 1-Hour Withdrawals, Expands Forex Offering with MT4 Integration
Jul 10, 2025 07:00: JST
|
|
|
Hola Prime Unveils 'Hola Prime Futures' with Industry-First 1-Hour Withdrawals, Expands Forex Offering with MT4 Integration
Jul 10, 2025 07:00 HKT/SGT
|
|
|
SAPPE's Female CEO Takes the World Stage at the Global Summit of Women 2025 in Berlin, Germany
Jul 9, 2025 22:00 HKT/SGT
|
|
|
康诺思腾自主创新研发的手术机器人 成功于英国启动首轮临床试验
Jul 9, 2025 20:35 HKT/SGT
|
|
|
Cornerstone Robotics Launches First Clinical Evaluation of its Hong Kong-Developed Surgical Robotic System in UK
Jul 9, 2025 20:32 HKT/SGT
|
|
|
康諾思騰自主創新研發的手術機械人 成功於英國啟動首輪臨床試驗
Jul 9, 2025 20:32 HKT/SGT
|
|
|
Standard Chartered GBA Business Confidence Survey points to further tariff drag in H2
Jul 9, 2025 18:55 HKT/SGT
|
|
|
港股最大機械人IPO!國配認購超30倍 極智嘉正式在香港交易所主板掛牌上市
Jul 9, 2025 17:05 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|